Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Interferon augments PML and PML/RAR alpha expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell line

K Nason-Burchenal, D Gandini, M Botto, J Allopenna, JR Seale, NC Cross, JM Goldman, E Dmitrovsky, PP Pandolfi

Blood (1996) 88 (10): 3926–3936.

https://doi.org/10.1182/blood.V88.10.3926.bloodjournal88103926

Published: 1996

Journal Articles

Molecular investigation of secondary chronic myeloid leukemia [letter]

RC Aguiar, H Sill, A Hochhaus, JM Goldman, NC Cross

Blood (1996) 88 (7): 2808–2809.

https://doi.org/10.1182/blood.V88.7.2808.bloodjournal8872808

Published: 1996

Journal Articles

A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia

A Hochhaus, A Reiter, H Skladny, JV Melo, C Sick, U Berger, JQ Guo, RB Arlinghaus, R Hehlmann, JM Goldman, NC Cross

Blood (1996) 88 (6): 2236–2240.

https://doi.org/10.1182/blood.V88.6.2236.bloodjournal8862236

Published: 1996

Journal Articles

p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias

F van Rhee, A Hochhaus, F Lin, JV Melo, JM Goldman, NC Cross

Blood (1996) 87 (12): 5213–5217.

https://doi.org/10.1182/blood.V87.12.5213.bloodjournal87125213

Published: 1996

Journal Articles

Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation

F Lin, F van Rhee, JM Goldman, NC Cross

Blood (1996) 87 (10): 4473–4478.

https://doi.org/10.1182/blood.V87.10.4473.bloodjournal87104473

Published: 1996

Journal Articles

Quantitation of mafosfamide-resistant pre-colony-forming units in allogeneic bone marrow transplantation: relationship with rate of engraftment and evidence for long-lasting reduction in stem cell numbers

MA Kirkland, A Spencer, RJ Davidson, C McDonald, JM Goldman

Blood (1996) 87 (9): 3963–3969.

https://doi.org/10.1182/blood.V87.9.3963.bloodjournal8793963

Published: 1996

Journal Articles

Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation

JG Zhang, F Lin, A Chase, JM Goldman, NC Cross

Blood (1996) 87 (6): 2588–2593.

https://doi.org/10.1182/blood.V87.6.2588.bloodjournal8762588

Published: 1996

Journal Articles

Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction

A Hochhaus, F Lin, A Reiter, H Skladny, PJ Mason, F van Rhee, PC Shepherd, NC Allan, R Hehlmann, JM Goldman, NC Cross

Blood (1996) 87 (4): 1549–1555.

https://doi.org/10.1182/blood.V87.4.1549.bloodjournal8741549

Published: 1996

Journal Articles

Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]

HJ Kolb, A Schattenberg, JM Goldman, B Hertenstein, N Jacobsen, W Arcese, P Ljungman, A Ferrant, L Verdonck, D Niederwieser

Blood (1995) 86 (5): 2041–2050.

https://doi.org/10.1182/blood.V86.5.2041.bloodjournal8652041

Published: 1995

Journal Articles

Myeloproliferative disorder associated with 8p11 translocations [letter; comment]

RC Aguiar, D Macdonald, PJ Mason, NC Cross, JM Goldman

Blood (1995) 86 (2): 834–835.

https://doi.org/10.1182/blood.V86.2.834.bloodjournal862834

Published: 1995

Journal Articles

BCR-ABL, ABL-BCR, BCR, and ABL genes are all expressed in individual granulocyte-macrophage colony-forming unit colonies derived from blood of patients with chronic myeloid leukemia

J Diamond, JM Goldman, JV Melo

Blood (1995) 85 (8): 2171–2175.

https://doi.org/10.1182/blood.V85.8.2171.bloodjournal8582171

Published: 1995

Journal Articles

Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia

H Sill, JM Goldman, NC Cross

Blood (1995) 85 (8): 2013–2016.

https://doi.org/10.1182/blood.V85.8.2013.bloodjournal8582013

Published: 1995

Journal Articles

Controls for reverse transcriptase-polymerase chain reaction amplification of BCR-ABL transcripts [letter]

JV Melo, NS Kent, XH Yan, JM Goldman

Blood (1994) 84 (11): 3984–3986.

https://doi.org/10.1182/blood.V84.11.3984.bloodjournal84113984

Published: 1994

Journal Articles

A special report: bone marrow transplants using volunteer donors-- recommendations and requirements for a standardized practice throughout the world--1994 update. The WMDA Executive Committee

JM Goldman

Blood (1994) 84 (9): 2833–2839.

https://doi.org/10.1182/blood.V84.9.2833.2833

Published: 1994

Journal Articles

Microsatellite instability in myeloid leukemias [letter; comment]

NC Cross, H Silly, JM Goldman

Blood (1994) 84 (9): 3236.

https://doi.org/10.1182/blood.V84.9.3236.3236

Published: 1994

Journal Articles

Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse

F van Rhee, F Lin, JO Cullis, A Spencer, NC Cross, A Chase, B Garicochea, J Bungey, J Barrett, JM Goldman

Blood (1994) 83 (11): 3377–3383.

https://doi.org/10.1182/blood.V83.11.3377.3377

Published: 1994

Journal Articles

Survival in chronic myelogenous leukemia [letter; comment]

JM Goldman

Blood (1994) 83 (5): 1443.

https://doi.org/10.1182/blood.V83.5.1443.1443

Published: 1994

Journal Articles

Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group

W Arcese, JM Goldman, E D'Arcangelo, A Schattenberg, A Nardi, JF Apperley, F Frassoni, F Aversa, HG Prentice, P Ljungman

Blood (1993) 82 (10): 3211–3219.

https://doi.org/10.1182/blood.V82.10.3211.3211

Published: 1993

Journal Articles

Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase [see comments]

JM Goldman, R Szydlo, MM Horowitz, RP Gale, RC Ash, K Atkinson, KA Dicke, E Gluckman, RH Herzig, A Marmont

Blood (1993) 82 (7): 2235–2238.

https://doi.org/10.1182/blood.V82.7.2235.2235

Published: 1993

Journal Articles

Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation

NC Cross, L Feng, A Chase, J Bungey, TP Hughes, JM Goldman

Blood (1993) 82 (6): 1929–1936.

https://doi.org/10.1182/blood.V82.6.1929.1929

Published: 1993

NARROW

Interferon augments PML and PML/RAR alpha expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell line

Molecular investigation of secondary chronic myeloid leukemia [letter]

A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia

p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias

Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation

Quantitation of mafosfamide-resistant pre-colony-forming units in allogeneic bone marrow transplantation: relationship with rate of engraftment and evidence for long-lasting reduction in stem cell numbers

Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation

Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction

Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]

Myeloproliferative disorder associated with 8p11 translocations [letter; comment]

BCR-ABL, ABL-BCR, BCR, and ABL genes are all expressed in individual granulocyte-macrophage colony-forming unit colonies derived from blood of patients with chronic myeloid leukemia

Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia

Controls for reverse transcriptase-polymerase chain reaction amplification of BCR-ABL transcripts [letter]

A special report: bone marrow transplants using volunteer donors-- recommendations and requirements for a standardized practice throughout the world--1994 update. The WMDA Executive Committee

Microsatellite instability in myeloid leukemias [letter; comment]

Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse

Survival in chronic myelogenous leukemia [letter; comment]

Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group

Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase [see comments]

Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only